Ifosfamide

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
62002
 Phase I study to determine the safety of Caelyx (Doxorubicin HCI, pegylated liposomal) in combination with Ifosfamide in previously untreated adult patients with advanced and/or metastatic soft tissues sarcomas.
30974
A ranomized phase III study of sequential high-dose Cisplatinum/Etoposide/Ifosfamide plus stem cell support versus BEP in patients with poor prognosis Germ Cell Cancer
08012
Pre-operative chemotherapy in resectable NSCLC. Randomised trial of surgical resection with or without pre-operative chemotherapy in patients with operable non small cell lung cancer (NSCLC) of any stage.
62981
 EURO-EWING 99 EUROpean Ewing tumour Working Initiative of National Groups Ewing Tumour Studies 1999
62012
Randomised trial of single agent doxorubicin versus doxorubicin plus ifosfamide in the first line treatment of advanced or metastatic soft tissue sarcoma

Back to Protocol section